Southampton Joint Formulary Formulary


	Southampton Joint Formulary

Search

Formulary Chapter 3: Respiratory system - Full Chapter

Notes:

View the local COPD Inhaled Therapy Prescribing Guidance here

Chapter Links...

NICE CG101: COPD guideline

NICE TA10: Asthma inhaler devices (children under 5)

NICE TA38: Asthma inhaler devices (older children 5-15years)

Details...

03.02

Corticosteroids

Beclometasone and formoterol (Fostair^®)
(MDI/DPI)

Formulary

Prescribing by brand name recommended

200/6 strength licensed for asthma only, not for COPD

Beclometasone dipropionate
(MDI/ breath actuated MDI)

Formulary

MHRA Drug Safety Update July 2008: prescribe CFC-free beclometasone metered-dose inhalers by brand name to reduce the risk of dosing errors

Note: Potencies and dosing recommendations may vary between brands. Refer to product SPC or BNF for more detailed advice.

MDI brands of choice in the Southampton locality are Soprobec (equivalent to Clenil brand) and Kelhale (equivalent to Qvar brand).

Kelhale brand is not licensed in children under 18 years.

Solent NHS Trust Beclometasone inhaler switches Nov 2019

Beclometasone/formoterol/glycopyrronium (Trimbow^®)
(MDI)

Formulary

Prescribing by brand name recommended

Budesonide
(DPI/nebules)

Formulary

Prescribing by brand name recommended

Budesonide and formoterol
(DPI)

Formulary

Prescribing by brand name recommended

Ciclesonide
(MDI)

Formulary

Specialist initiation only. For add on treatment in severe asthma as a steroid sparing agent.

Fluticasone /umeclidinium / vilanterol

(Trelegy Ellipta^®)
(DPI)

Formulary

Prescribing by brand name recommended

Fluticasone furoate and vilanterol (Relvar Ellipta^®)
(DPI)

Formulary

Prescribing by brand name recommended

Higher strength formulation (184/22) licensed only for asthma, not for COPD

Fluticasone propionate
(MDI/DPI)

Formulary

Prescribing by brand name recommended

Fluticasone propionate and formoterol (Flutiform^®)
(MDI)

Formulary

Prescribing by brand name recommended

Licensed for asthma only, not for COPD

NICE TA131: Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years

NICE TA138: Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over

....

Non Formulary Items

Budesonide (Budelin Novolizer^®)
(inhalation powder)

Non Formulary

Fluticasone propionate and salmeterol (Sirdupla^®, Seretide^®)
(MDI)

Non Formulary

Mometasone Furoate (Asmanex^®)

Non Formulary

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine

Traffic Light Status Information

Status	Description
	Suitable for prescribing by all in both primary and secondary care.
	Specialist recommended but suitable for continuation in primary care.
	Specialist initiated but suitable for continuation in primary care.
	Specialist initiated and for continuation in primary care under a locally approved shared care guideline.
	Suitable for prescribing in specialist settings (secondary care) only.
	Secondary care medicines to be used under specialised commissioning arrangements only.
	For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy.
	Not recommended for use.